NOOSPHERE

Public document records

Bibliographic records with public provenance and stable links. The catalog does not include all documents in the corpus or reproduce their full texts.

98,186 public records · page 661 / 982

  1. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease2014 · OpenAlex
  2. Molecular pathways in non-alcoholic fatty liver disease2014 · OpenAlex
  3. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia2014 · OpenAlex
  4. Monitoring the stability of risk factors for adolescent cannabis use2014 · Crossref
  5. Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome2014 · OpenAlex
  6. Monoamine oxidase a gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder2014 · OpenAlex
  7. Monoamine Oxidase Inhibitory Constituents of Propolis: Kinetics and Mechanism of Inhibition of Recombinant Human MAO-A and MAO-B2014 · OpenAlex
  8. Mood, food, and obesity2014 · OpenAlex
  9. Morality Framing in U.S. Drug Control Policy: An Example From Marijuana Decriminalization2014 · Crossref
  10. Morphine and Clonidine Combination Therapy Improves Therapeutic Window in Mice: Synergy in Antinociceptive but Not in Sedative or Cardiovascular Effects2014 · OpenAlex
  11. Motherhood, Psychological Risks, and Resources in Relation to Alcohol Use Disorder: Are There Differences between Black and White Women?2014 · Crossref
  12. Mothers of Sons with Substance Use Disorders: A Grounded Theory Approach Revealing Maternal Expectations and Three Stages of Change2014 · Crossref
  13. Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic2014 · OpenAlex
  14. mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse2014 · OpenAlex
  15. Multi-Platform Metabolomic Analyses of Ergosterol-Induced Dynamic Changes in Nicotiana tabacum Cells2014 · OpenAlex
  16. Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: outcomes of the INCANT trial2014 · OpenAlex
  17. Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial2014 · OpenAlex
  18. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats2014 · OpenAlex
  19. Multiorgan Dysfunction Related to Chronic Ketamine Abuse2014 · OpenAlex
  20. Multiple Oral Therapeutics Suppress Repressors (LSD-1, HDACs, and BCL11A) of Gamma Globin Gene Expression2014 · Crossref
  21. Multiple tobacco product use among US adolescents and young adults2014 · OpenAlex
  22. Multiple Victimizations Before and After Leaving Home Associated With PTSD, Depression, and Substance Use Disorder Among Homeless Youth2014 · Crossref
  23. Muscle dysmorphia: Could it be classified as an addiction to body image?2014 · OpenAlex
  24. Music helps addicted patients to reduce negative emotions in everyday life2014 · OpenAlex
  25. Muskrat theories, tobacco in the streets, and living Chicago as Indigenous land2014 · OpenAlex
  26. Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB 1 R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice2014 · OpenAlex
  27. n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and α-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease2014 · OpenAlex
  28. Nalmefene: first drug for reducing alcohol consumption2014 · Crossref
  29. Naloxone for Opioid Overdose Prevention2014 · OpenAlex
  30. Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial2014 · OpenAlex
  31. Naltrexone for impulse control disorders in Parkinson disease2014 · OpenAlex
  32. Naltrexone Improves Quit Rates, Attenuates Smoking Urge, and Reduces Alcohol Use in Heavy Drinking Smokers Attempting to Quit Smoking2014 · Crossref
  33. Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date2014 · OpenAlex
  34. Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss2014 · OpenAlex
  35. Narconovela: four case studies of the representation of drug trafficking in Mexican fiction2014 · OpenAlex
  36. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005–20092014 · OpenAlex
  37. National Survey of Oral/Dental Conditions Related to Tobacco and Alcohol Use in Mexican Adults2014 · Crossref
  38. Natural Cinnamic Acids, Synthetic Derivatives and Hybrids with Antimicrobial Activity2014 · OpenAlex
  39. Natural course of cannabis use disorders2014 · Crossref
  40. Natural History of Attempts to Stop Smoking2014 · OpenAlex
  41. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in C hina2014 · OpenAlex
  42. Needs of Aboriginal Australian women with comorbid mental and alcohol and other drug use disorders2014 · Crossref
  43. Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment2014 · OpenAlex
  44. Neighborhood Poverty, College Attendance, and Diverging Profiles of Substance Use and Allostatic Load in Rural African American Youth2014 · Crossref
  45. Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone2014 · Crossref
  46. Neonatal pain and COMT Val158Met genotype in relation to serotonin transporter (SLC6A4) promoter methylation in very preterm children at school age2014 · OpenAlex
  47. Network correlates of sexual health advice seeking and substance use among members of the Los Angeles House and Ball communities2014 · OpenAlex
  48. Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction2014 · Crossref
  49. Neural Correlates of Sexual Cue Reactivity in Individuals with and without Compulsive Sexual Behaviours2014 · OpenAlex
  50. Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis2014 · OpenAlex
  51. Neurobiological Augmentation of Psychotherapy in Treatment Resistant Depression2014 · OpenAlex
  52. Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos2014 · OpenAlex
  53. Neurocognition in college-aged daily marijuana users.2014 · PubMed
  54. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression2014 · OpenAlex
  55. Neuroimaging craving: urge intensity matters2014 · Crossref
  56. Neuroimaging Studies of Acute Effects of THC and CBD in Humans and Animals: a Systematic Review2014 · OpenAlex
  57. Neuroimmune basis of methamphetamine toxicity.2014 · PubMed
  58. Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid2014 · OpenAlex
  59. Neurologic Complications of Illicit Drug Abuse2014 · OpenAlex
  60. Neurological Effects of Honey: Current and Future Prospects2014 · OpenAlex
  61. Neuronal substrates and functional consequences of prenatal cannabis exposure.2014 · PubMed
  62. Neuropathology of Chronic Alcohol Abuse2014 · Crossref
  63. Neuropathology of substance use disorders.2014 · PubMed
  64. NEUROPROTECTIVE EVALUATION OF LEAF EXTRACT OF DALBERGIA SISSOO IN 3-NITROPROPIONIC ACID INDUCED NEUROTOXICITY IN RATS2014 · Crossref
  65. Neuropsychological Functioning among Chronic Khat Users in Jazan Region, Saudi Arabia2014 · Crossref
  66. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.2014 · PubMed
  67. New Biomarkers of Coffee Consumption Identified by the Non-Targeted Metabolomic Profiling of Cohort Study Subjects2014 · OpenAlex
  68. New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature2014 · OpenAlex
  69. New Developments in Understanding and Treating Adolescent Marijuana Dependence2014 · OpenAlex
  70. New Drugs on the Internet: The Case of Camfetamine2014 · OpenAlex
  71. New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons2014 · OpenAlex
  72. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?2014 · PubMed
  73. New psychoactive substances legislation in Ireland – Perspectives from academia2014 · Crossref
  74. New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron2014 · OpenAlex
  75. New Research Findings Since the 2007 Surgeon General’s Call to Action to Prevent and Reduce Underage Drinking: A Review2014 · OpenAlex
  76. NicolasLanglitz. NEUROPSYCHEDELIA: The Revival of Hallucinogen Research since the Decade of the Brain. Berkeley: University of California Press, 2012.2014 · OpenAlex
  77. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices.2014 · PubMed
  78. Nicotine Effects and the Endogenous Opioid System2014 · OpenAlex
  79. Nicotine‐induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids2014 · Crossref
  80. Nipping Cue Reactivity in the Bud: Baclofen Prevents Limbic Activation Elicited by Subliminal Drug Cues2014 · OpenAlex
  81. Nitrite Inhalants Use and HIV Infection among Men Who Have Sex with Men in China2014 · OpenAlex
  82. Nitrous Oxide (N2O)-Induced Acute Psychosis2014 · OpenAlex
  83. NMDA receptor structures reveal subunit arrangement and pore architecture.2014 · PubMed
  84. No Water No Coffee—Yes Coffee Yes Water2014 · Crossref
  85. Non-medical prescribers and benzodiazepines: A qualitative study2014 · Crossref
  86. Non-medical prescription drug and illicit street drug use among young Swiss men and associated mental health issues2014 · Crossref
  87. Non-Partner Violence Against Women Who Use Drugs in San Francisco2014 · Crossref
  88. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results2014 · OpenAlex
  89. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies2014 · OpenAlex
  90. Nonopioid Drugs in the Treatment of Cancer Pain2014 · OpenAlex
  91. Nonproblematic Illegal Drug Use2014 · Crossref
  92. Normative misperceptions about alcohol use in the general population of drinkers: A cross-sectional survey2014 · OpenAlex
  93. Norway tries naloxone in spray form to prevent deaths from drug overdose2014 · OpenAlex
  94. Notes on the Expansion and Reinvention of Ayahuasca Shamanism2014 · OpenAlex
  95. Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation2014 · OpenAlex
  96. Novel Psychoactive Substances and Behavioral Addictions2014 · OpenAlex
  97. Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment2014 · OpenAlex
  98. Nutraceuticals as potential therapeutic agents for colon cancer: a review2014 · OpenAlex
  99. NutriPhysioGenomics applications to identify adaptations of cattle to consumption of ergot alkaloids and inorganic versus organic forms of selenium: altered nutritional, physiological and health states?2014 · Crossref
  100. N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities2014 · OpenAlex